4 reports

  • BRAINSTORM CELL THERAPEUTICS INC, KEY COMPETITORS
  • Deal Type

The company' s deal volume increased from one pharmaceuticals & healthcare deal in 2016 to two pharmaceuticals & healthcare deals in 2017.

  • Pharmaceutical
  • Therapy
  • United States
  • Company
  • BrainStorm Cell Therapeutics Inc.

Huntington Disease - Overview Huntington Disease - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR HUNTINGTON DISEASE, H## 2017 PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR HUNTINGTON DISEASE, H## 2017 Phase III ## ## Phase II ## ## Phase I ## ## Preclinical ## ## D

  • Dementia
  • Pharmaceutical
  • Therapy
  • Company
  • BrainStorm Cell Therapeutics Inc.
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018 (CONTD..2), H1 2018

Huntington Disease - Overview Huntington Disease - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR HUNTINGTON DISEASE, H## 2018 PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR HUNTINGTON DISEASE, H## 2018 Phase III ## ## Phase II ## ## Phase I ## ## Preclinical ## ## D

  • Dementia
  • Pharmaceutical
  • Therapy
  • Company
  • BrainStorm Cell Therapeutics Inc.

PARTNER ##: MELINTA THERAPEUTICS, INC.

  • Hospital
  • Pharmaceutical
  • Therapy
  • Company
  • BrainStorm Cell Therapeutics Inc.